Research and Markets: Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H2 2013

DUBLIN–(BUSINESS WIRE)–

Research and Markets(http://www.researchandmarkets.com/research/6t3qdm/secondary) has announced the addition of the“Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H2 2013” report to their offering.

‘Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Secondary Progressive Multiple Sclerosis (SPMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Secondary Progressive Multiple Sclerosis (SPMS).

Scope

– A snapshot of the global therapeutic scenario for Secondary Progressive Multiple Sclerosis (SPMS).

– A review of the Secondary Progressive Multiple Sclerosis (SPMS) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

– Coverage of products based on various stages of development ranging from discovery till registration stages.

– A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

– Coverage of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline on the basis of route of administration and molecule type.

– Key discontinued pipeline projects.

– Latest news and deals relating to the products.

Companies Mentioned

click here to continue

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews